You are here

  • Home
  • Archive
  • Volume 15, Issue 5
  • Effect of combined rapid access point-of-care intestinal ultrasound clinic on the management of inflammatory bowel disease

Article Text

Article menu
Download PDFPDF
Small bowel and nutrition
Original research
Effect of combined rapid access point-of-care intestinal ultrasound clinic on the management of inflammatory bowel disease
  1. Nigel Grunshaw1,
  2. Wendi Harrison2,
  3. Hayley Owen2,
  4. Philip J Smith3
  1. 1 Radiology Dept, University Hospitals of Morecambe Bay NHS Trust, Barrow in Furness, Cumbria, UK
  2. 2 Gastroenterology Dept, University Hospitals of Morecambe Bay NHS Trust, Barrow in Furness, Cumbria, UK
  3. 3 Honorary Consultant Gastroenterologist, Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
  1. Correspondence to Dr Nigel Grunshaw; nigel.grunshaw{at}btinternet.com

Abstract

Background Intestinal ultrasound (IUS), although less widely practiced in the UK, offers several advantages in inflammatory bowel disease (IBD), particularly with regard to the accessibility of the test and immediate availability of reports.

Aims To assess the use of point-of-care IUS in influencing management change in IBD.

Methods A retrospective service evaluation review of 3 years of a rapid access IUS clinic performed in combination with IBD nurses in a District General Hospital setting.

Results A total of 227 examinations were performed on 168 patients. All scans were performed by a consultant radiologist. 162 examinations (79%) were scanned and reported within 2 weeks of referral. 101/227 (44%) had evidence of significant active/obstructing disease, and in patients with known IBD, this rises to 101/185 (55%). Overall, 59.5% (135) of ultrasound examinations resulted in management changes.

Conclusion Wider adoption of IUS in a point-of-care setting has the potential to significantly guide patient management in IBD.

  • INFLAMMATORY BOWEL DISEASE
  • CROHN'S DISEASE
  • ULCERATIVE COLITIS
  • ULTRASONOGRAPHY
  • CLINICAL DECISION MAKING

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

https://doi.org/10.1136/flgastro-2024-102747

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    All data relevant to the study are included in the article or uploaded as supplementary information.

    View Full Text

    Footnotes

    • Contributors Study guarantor: NG. NG and WH devised the service. NG devised the initial concept and wrote the initial draft of the manuscript. WH, NG and HO were responsible for the patient data. PJS critically revised the manuscript. All authors approved the final manuscript for submission.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests NG has served as a speaker for Canon Medical Systems, Tillots, Janssen and AbbVie. WH has served as a speaker for Tillots and AbbVie. HO has served as a speaker for Janssen AbbVie and Eli Lilly. PJS has served as a speaker and advisory board member for Janssen, Takeda, Tillotts, Galapagos, AbbVie, BMS, Dr Falk, Eli Lilly, Amgen, Fresenius Kabi and Celltrion. PJS is an Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital. PJS is the Deputy Editor of Frontline Gastroenterology at the time of submission.

    • Provenance and peer review Not commissioned; externally peer reviewed.